Ibritumomab (Zevalin)

Indications

  • xxxx

Pharmacology

  • Radioimmunotherapeutic Agent, Consisting of Murine Anti-Human CD20 Monoclonal Antibody Conjugated with the Chelating Agent Tiuxetan (see Anti-CD20 Therapy, [[Anti-CD20 Therapy]]): tiuxetan chelates the radioisotopes indium-111 and yttrium-90

Administration

  • xxx

Adverse Effects

Other Adverse Effects

  • xxxx

References

  • xxxx